Furthermore, onvansertib effectively reduced tumor growth in the transgenic LKB1fl/flp53fl/fl mouse model of endometrioid EC, which was accompanied by a reduction in the protein expression of Ki-67 and Plk1 and an increase in the expression of Bcl-xL in tumor tissues. Here, BCL2L1 is linked to neoplasm.